This stands for B Cell Maturation Antigen (BCMA) and includes treatments such as ide-cel, cilta-cel, teclistamab, elranatamab, linvoseltamab or belantamab mafodotin.
GPRC5D Exposure
CAR-T Exposure
BCL-2 Exposure
Treatment Classifications
Explore trials based on treatment classification/type.
Targets
Explore trials based on treatment targets.
Enrollment Status
Only display trials that are active and accepting at Huntsman Cancer Center.